PIERIS Proteolab
Develops innovative protein-based therapies with strategic partnerships to improve clinical outcomes.
Market cap
$18.0m
Enterprise value
($8m)
Share price
$13.60 PIRS
Company register number
HRB 221043 (München)
Authorizing premium user...